Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Amino Acid [EPC]
Sus Scrofa Rectal Mucosa is a biological extract derived from porcine tissue, utilized in clinical settings as an anti-coagulant, calculi dissolution agent, and allergenic extract. It functions through acidifying and calcium-chelating mechanisms to manage complex metabolic and hematologic conditions...
Name
Sus Scrofa Rectal Mucosa
Raw Name
SUS SCROFA RECTAL MUCOSA
Category
Amino Acid [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Sus Scrofa Rectal Mucosa
Sus Scrofa Rectal Mucosa is a biological extract derived from porcine tissue, utilized in clinical settings as an anti-coagulant, calculi dissolution agent, and allergenic extract. It functions through acidifying and calcium-chelating mechanisms to manage complex metabolic and hematologic conditions.
Detailed information about Sus Scrofa Rectal Mucosa
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Rectal Mucosa.
Sus Scrofa Rectal Mucosa refers to a biological medicinal substance derived from the mucosal lining of the rectum of the domestic pig (Sus scrofa). In the pharmacological landscape of 2026, this substance is classified under several Established Pharmacologic Classes (EPC), including Amino Acid [EPC], Calculi Dissolution Agent [EPC], Anti-coagulant [EPC], and Non-Standardized Food Allergenic Extract [EPC]. Because it is a biological extract, it contains a complex matrix of proteins, glycosaminoglycans (such as heparin precursors), and essential amino acids that contribute to its multi-faceted therapeutic profile.
Historically, porcine-derived tissues have been a cornerstone of pharmaceutical development, most notably in the production of heparin. Sus Scrofa Rectal Mucosa specifically is utilized in specialized clinical formulations designed to address urolithiasis (the formation of stony concretions in the bladder or urinary tract) and as a diagnostic tool in allergy medicine. According to the FDA-approved labeling for biological extracts, these products must undergo rigorous purification to ensure the removal of zoonotic pathogens while maintaining the integrity of the bioactive proteins. Healthcare providers typically utilize this agent when specific acidifying or chelating actions are required that cannot be met by synthetic alternatives.
The mechanism of action for Sus Scrofa Rectal Mucosa is dual-pronged, involving Acidifying Activity [MoA] and Calcium Chelating Activity [MoA]. At the molecular level, the extract contains high concentrations of acidic glycosaminoglycans. When introduced into the systemic or localized environment, these molecules facilitate the sequestration of calcium ions ($Ca^{2+}$). This chelation process is critical for the dissolution of calcium-based calculi (stones). By binding to the calcium within the crystalline structure of a stone, the extract promotes the breakdown of the mineral matrix, allowing for easier passage or gradual dissolution.
Furthermore, the acidifying activity of the extract modifies the pH of the surrounding physiological fluid. In the context of urinary health, maintaining an acidic environment is often necessary to prevent the precipitation of certain types of mineral salts. Additionally, the anti-coagulant properties are attributed to the presence of heparin-like molecules within the rectal mucosa. These molecules interact with antithrombin III, accelerating its ability to inhibit thrombin and Factor Xa, thereby slowing the coagulation cascade. In diagnostic use, the extract serves as a non-standardized food allergenic extract, where it is used in skin prick testing to identify hypersensitivity reactions to porcine proteins.
Understanding the pharmacokinetics of a biological extract like Sus Scrofa Rectal Mucosa is complex due to its heterogeneous nature.
Sus Scrofa Rectal Mucosa is utilized for several distinct clinical indications:
This ingredient is available in various delivery formats depending on the therapeutic intent:
> Important: Only your healthcare provider can determine if Sus Scrofa Rectal Mucosa is right for your specific condition. The choice of formulation depends heavily on whether the goal is systemic anticoagulation or localized mineral dissolution.
Dosage for Sus Scrofa Rectal Mucosa must be strictly individualized by a healthcare professional based on the patient's weight, clinical condition, and the specific therapeutic goal.
The safety and efficacy of Sus Scrofa Rectal Mucosa in pediatric populations have not been extensively established. In cases where it is used for allergenic testing, the dose is similar to adults but must be performed under strict medical supervision in a facility equipped for emergency resuscitation. For other indications, pediatric use is generally avoided unless the potential benefits significantly outweigh the risks, and no alternative treatments are available. Your pediatrician will determine the appropriate course based on the child's body surface area and metabolic maturity.
Patients with impaired kidney function (reduced Glomerular Filtration Rate) require careful monitoring. Because the metabolites and chelating complexes are cleared renally, a dose reduction of 25% to 50% may be necessary in patients with Stage 3 or Stage 4 chronic kidney disease to prevent accumulation and potential toxicity.
While the primary metabolism occurs via proteases, severe hepatic impairment can alter the synthesis of endogenous clotting factors. Patients with Child-Pugh Class B or C cirrhosis should be monitored closely for increased bleeding tendencies when taking Sus Scrofa Rectal Mucosa.
Geriatric patients often exhibit reduced renal clearance and increased vascular fragility. Clinical guidelines suggest starting at the lower end of the dosing range (e.g., 200 mg daily for oral forms) and titrating upward slowly based on tolerability and clinical response.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of excessive anticoagulation or gastrointestinal distress.
Signs of overdose may include unexplained bruising, nosebleeds (epistaxis), blood in the stool (melena), or severe abdominal pain. In the event of an overdose, seek emergency medical attention immediately. Treatment typically involves supportive care and, in the case of excessive anticoagulation, the administration of protamine sulfate may be considered by a physician to neutralize the heparin-like activity.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to the recurrence of calculi or thrombotic events.
Patients taking Sus Scrofa Rectal Mucosa frequently report mild gastrointestinal symptoms. These may include:
> Warning: Stop taking Sus Scrofa Rectal Mucosa and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Sus Scrofa Rectal Mucosa (exceeding 6 months) requires periodic monitoring of bone density and hematologic parameters. There is a theoretical risk of developing a permanent sensitivity to porcine products, which could complicate future medical treatments involving pig-derived heart valves or insulin. Additionally, the chronic acidifying effect of the drug may alter the systemic acid-base balance, necessitating regular electrolyte checks.
There are currently no FDA black box warnings specifically for "Sus Scrofa Rectal Mucosa" as a raw extract. However, when the extract is processed into Heparin, it carries significant warnings regarding the risk of spinal/epidural hematomas in patients receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas can result in long-term or permanent paralysis. Healthcare providers must assess the timing of Sus Scrofa Rectal Mucosa administration relative to any planned spinal procedures.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Sus Scrofa Rectal Mucosa is a biological product derived from animal tissue. Patients must be aware that while modern purification techniques are highly effective, the product carries the inherent characteristics of its porcine origin. This medication should only be used under the supervision of a physician familiar with biological extracts and their potential impact on coagulation and mineral metabolism.
No FDA black box warnings are currently issued for the raw extract Sus Scrofa Rectal Mucosa. However, patients using formulations with high anti-coagulant activity must be monitored for the same risks associated with standardized heparin, particularly the risk of spinal hematoma during spinal anesthesia.
To ensure safety, your doctor will likely require the following tests:
Sus Scrofa Rectal Mucosa generally does not cause sedation. However, if you experience dizziness or lightheadedness as a side effect, you should avoid driving or operating heavy machinery until you know how the medication affects you.
Alcohol consumption should be limited or avoided while taking this medication. Alcohol can increase the risk of gastrointestinal bleeding and may interfere with the liver's ability to process the amino acid components of the extract. Furthermore, alcohol can exacerbate the formation of certain types of urinary calculi, counteracting the therapeutic effects of the drug.
Do not stop taking Sus Scrofa Rectal Mucosa abruptly if you are using it for its anti-coagulant properties, as this may lead to a rebound hypercoagulable state (increased risk of clots). If discontinuation is necessary, your doctor will provide a tapering schedule or transition you to an alternative therapy.
> Important: Discuss all your medical conditions, including any history of bleeding, kidney stones, or animal allergies, with your healthcare provider before starting Sus Scrofa Rectal Mucosa.
For each major interaction, the management strategy usually involves either a dose adjustment of the interacting drug or increased frequency of clinical monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers and vitamins.
Sus Scrofa Rectal Mucosa must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician include:
Patients who are sensitive to bovine (cow) derived products may occasionally show cross-sensitivity to porcine extracts, although this is less common than direct pork allergy. Additionally, those with a known sensitivity to Heparin or Heparinoids must be treated as potentially sensitive to Sus Scrofa Rectal Mucosa.
> Important: Your healthcare provider will evaluate your complete medical history, including any surgical history and allergies, before prescribing Sus Scrofa Rectal Mucosa. Always disclose if you have any religious or ethical objections to animal-derived medications.
Sus Scrofa Rectal Mucosa is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm when administered to a pregnant woman. However, the anti-coagulant components (heparin-like) do not cross the placenta, making them generally preferred over oral anti-coagulants like warfarin if anticoagulation is strictly necessary during pregnancy. Nonetheless, the use of a biological extract during the first trimester should be avoided unless the clinical need is urgent. There is a risk of maternal hemorrhage, particularly during delivery, if the extract's anti-coagulant effects are active.
It is not known whether the components of Sus Scrofa Rectal Mucosa are excreted in human milk. Because many proteins and large molecules are destroyed in the infant's digestive tract, the risk to a nursing infant is likely low. However, due to the lack of definitive safety data, caution should be exercised. Healthcare providers may recommend monitoring the infant for unusual bruising or changes in stool if the mother is taking high doses of the extract.
As previously noted, Sus Scrofa Rectal Mucosa is not routinely approved for use in children except for diagnostic allergenic testing. The potential for the extract to interfere with mineral metabolism and bone growth in developing children is a significant concern. If used, pediatric patients must be under the care of a specialist (such as a pediatric urologist or immunologist) and monitored with frequent blood and imaging tests.
Patients over the age of 65 are at a higher risk for adverse effects. Age-related declines in kidney function mean the drug may stay in the system longer, increasing the risk of bleeding. Furthermore, the elderly are more prone to falls; an injury while on an anti-coagulant can lead to severe internal bleeding. Physicians typically recommend a lower starting dose and frequent monitoring of renal function and coagulation parameters in this population.
In patients with a GFR below 30 mL/min, the clearance of the calcium-chelating complexes is significantly delayed. This can lead to an accumulation of the drug and potentially cause electrolyte imbalances. Dose adjustments are mandatory, and in some cases, the drug may be contraindicated if the patient is on dialysis, as the clearance through dialysis membranes is unpredictable.
In severe liver disease, the body's ability to produce clotting factors is compromised. Adding an external anti-coagulant extract can lead to a dangerous synergistic effect, resulting in spontaneous bleeding. Patients with a Child-Pugh score of 7 or higher (Class B and C) require extremely close monitoring and lower dosages.
> Important: Special populations require individualized medical assessment. Always inform your specialist about your age, pregnancy status, or any organ impairment.
Sus Scrofa Rectal Mucosa acts as a multi-target biological agent. Its primary molecular targets include:
The onset of the anti-coagulant effect is rapid when given parenterally (within 20-60 minutes). The duration of effect typically lasts 8 to 12 hours. For calculi dissolution, the effect is cumulative and may take several weeks of consistent dosing to show a reduction in stone size on imaging. There is no evidence of significant tolerance development with short-term use, though long-term use can lead to secondary changes in bone metabolism.
| Parameter | Value |
|---|---|
| Bioavailability | 20-30% (Oral), 90%+ (Subcutaneous) |
| Protein Binding | 85% to 95% (primarily to Albumin) |
| Half-life | 1.5 - 5 hours |
| Tmax | 2 - 4 hours (Oral/SC) |
| Metabolism | Heparinases and cellular proteases |
| Excretion | Renal 60%, Fecal 40% |
Sus Scrofa Rectal Mucosa is a biological extract. Within the therapeutic hierarchy, it is grouped with other porcine-derived products such as Heparin Sodium and Porcine Thyroid extracts. It serves as a natural alternative to synthetic calcium chelators and anticoagulants.
Common questions about Sus Scrofa Rectal Mucosa
Sus Scrofa Rectal Mucosa is primarily used for three distinct medical purposes: as an anti-coagulant to prevent blood clots, as a calculi dissolution agent to help break down kidney or bladder stones, and as an allergenic extract for diagnostic testing. Its ability to chelate calcium and acidify physiological environments makes it effective for managing mineral-based stones. Additionally, the heparin-like molecules within the extract provide significant blood-thinning properties. Healthcare providers may also use it in diagnostic settings to identify pork-related allergies. It is always used as part of a comprehensive treatment plan under medical supervision.
The most frequently reported side effects include gastrointestinal upset, such as nausea, dyspepsia, and mild diarrhea, particularly with oral forms. For those receiving the medication via injection, localized reactions like redness, itching, or minor swelling at the site are common. Some patients may also notice an increase in minor bruising or a tendency to bleed slightly longer from small cuts. Dizziness and mild headaches have also been reported by a small percentage of users. Most of these symptoms are mild and tend to resolve as the body adjusts to the medication. However, any persistent or worsening symptoms should be discussed with a doctor.
It is generally recommended to avoid or strictly limit alcohol consumption while taking Sus Scrofa Rectal Mucosa. Alcohol can irritate the stomach lining, which, when combined with the anti-coagulant effects of the drug, significantly increases the risk of gastrointestinal bleeding. Furthermore, alcohol can interfere with the metabolic processes required to break down the amino acids in the extract. Chronic alcohol use can also contribute to the formation of new kidney stones, potentially negating the benefits of the medication. Always consult your healthcare provider regarding your specific alcohol intake and how it may interact with your treatment.
Sus Scrofa Rectal Mucosa is classified as Pregnancy Category C, meaning its safety has not been definitively established through large-scale human studies. While the large molecules in the extract generally do not cross the placenta, there is a risk of maternal bleeding complications, especially during labor and delivery. It is typically only prescribed during pregnancy if the potential benefits to the mother clearly outweigh the risks to the fetus. If you are pregnant or planning to become pregnant, you must discuss the risks and benefits with your obstetrician. Alternative treatments may be considered depending on the clinical indication.
The time it takes for the medication to work depends on the condition being treated. For anti-coagulation, the effects begin within 20 to 60 minutes of an injection and are monitored via blood tests. However, when used for the dissolution of kidney or bladder stones, the process is much slower. It may take several weeks or even months of consistent daily use before a noticeable reduction in stone size is visible on an ultrasound or CT scan. Patients are encouraged to remain patient and strictly follow their dosing schedule. Your doctor will use periodic imaging and lab work to track your progress.
You should never stop taking Sus Scrofa Rectal Mucosa suddenly without consulting your doctor, especially if you are using it for its anti-coagulant properties. Abruptly discontinuing a blood thinner can lead to a 'rebound' effect, where the risk of developing a dangerous blood clot increases significantly. If the medication needs to be stopped due to side effects or upcoming surgery, your doctor will provide a safe tapering plan. For stone dissolution, stopping suddenly may cause the stones to begin growing again or lead to the formation of new crystals. Always seek medical advice before making changes to your regimen.
If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular timing. Never take two doses at once to make up for a missed one, as this can lead to excessive levels of the drug in your system and increase the risk of bleeding. Consistency is key, particularly for the anti-coagulant effects. If you find yourself frequently missing doses, consider using a pill organizer or setting an alarm on your phone. Inform your doctor if you miss multiple doses in a row.
Weight gain is not a commonly reported side effect of Sus Scrofa Rectal Mucosa. The medication primarily affects blood coagulation and mineral metabolism rather than metabolic rate or fat storage. However, if you experience sudden weight gain accompanied by swelling in the ankles or feet (edema), you should contact your doctor, as this could indicate a change in kidney or heart function. Some patients may experience changes in appetite due to gastrointestinal side effects, but this more often leads to weight loss or maintenance. Any significant, unexplained change in weight should be evaluated by a healthcare professional.
Sus Scrofa Rectal Mucosa can interact with several other medications, particularly those that also affect blood clotting. Taking it with aspirin, ibuprofen, or prescription blood thinners like warfarin can dangerously increase your risk of bleeding. It may also interact with calcium supplements, which can counteract the drug's ability to dissolve stones. Because it is a biological extract, it is vital to provide your doctor with a complete list of all medications, vitamins, and herbal supplements you are taking. Your pharmacist can also help check for potential interactions before you start a new prescription.
Sus Scrofa Rectal Mucosa is a biological substance, and 'generic' versions in the traditional sense do not exist for biologicals. Instead, there may be 'biosimilar' products or different brands of porcine mucosal extracts available. The availability depends on the specific formulation and the country in which you reside. Some components, like Heparin, are widely available from multiple manufacturers, while specialized calculi dissolution formulas may be proprietary. Always check with your pharmacist to ensure you are receiving the specific formulation prescribed by your doctor, as different biological extracts are not always interchangeable.